Nutra Pharma NPHC Peer Comparison

OTC NPHC
$0.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Peer Comparison

300 Comparable Companies

Industry Personal Care Products

The table below compares all 300 Personal Care Products companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 KVUE Kenvue Inc. primary S-11 Household and Personal Products SG-05 34.17 Bn 20.61 0.00 Mn 33.06 Bn
2 KMB Kimberly Clark Corp primary S-11 Household and Personal Products SG-05 32.86 Bn 18.50 0.00 Mn 31.91 Bn
3 BBWI Bath & Body Works, Inc. primary S-11 Household and Personal Products SG-05 3.85 Bn 5.81 0.00 Mn 3.05 Bn
4 PRGO PERRIGO Co plc primary S-11 Household and Personal Products SG-05 1.99 Bn -1.15 0.00 Mn 1.59 Bn
5 HLF Herbalife Ltd. primary S-11 Household and Personal Products SG-05 1.32 Bn 5.18 0.00 Mn 0.95 Bn
6 EPC EDGEWELL PERSONAL CARE Co primary S-11 Household and Personal Products SG-05 1.24 Bn -17.89 0.00 Mn 0.84 Bn
7 RAJAF TFA Therapeutics, Inc. primary S-11 Household and Personal Products SG-05 1.02 Bn — 0.00 Mn 1.02 Bn
8 HNST Honest Company, Inc. primary S-11 Household and Personal Products SG-05 0.60 Bn -49.65 0.00 Mn 0.50 Bn
9 USNA Usana Health Sciences Inc primary S-11 Household and Personal Products SG-05 0.28 Bn -9.51 0.00 Mn 0.11 Bn
10 BFNH Bioforce Nanosciences Holdings, Inc. primary S-11 Household and Personal Products SG-05 0.26 Bn -2,541.40 — 0.26 Bn
11 NATR Natures Sunshine Products Inc primary S-11 Household and Personal Products SG-05 0.24 Bn 13.00 0.00 Mn 0.16 Bn
12 NAGE Niagen Bioscience, Inc. primary S-11 Household and Personal Products SG-05 0.24 Bn 15.13 0.00 Mn 0.18 Bn
13 MED Medifast Inc primary S-11 Household and Personal Products SG-05 0.13 Bn -5.26 0.00 Mn -0.04 Bn
14 LFVN Lifevantage Corp primary S-11 Household and Personal Products SG-05 0.08 Bn 17.30 0.00 Mn 0.07 Bn
15 GWLL Goldenwell Biotech, Inc. primary S-11 Household and Personal Products SG-05 0.07 Bn -574.97 1.26 Mn 0.07 Bn
16 CFOO China Foods Holdings Ltd. primary S-11 Household and Personal Products SG-05 0.02 Bn -75.98 0.00 Mn 0.02 Bn
17 HYEX Healthy Extracts Inc. primary S-11 Household and Personal Products SG-05 0.02 Bn -18.49 0.00 Mn 0.02 Bn
18 MTEX Mannatech Inc primary S-11 Household and Personal Products SG-05 0.02 Bn -1.04 0.00 Mn 0.01 Bn
19 DSY Big Tree Cloud Holdings Ltd primary S-11 Household and Personal Products SG-05 0.02 Bn — — 0.01 Bn
20 NHTC Natural Health Trends Corp primary S-11 Household and Personal Products SG-05 0.01 Bn -8.40 0.00 Mn 0.00 Bn
21 LIMX Limitless X Holdings Inc. primary S-11 Household and Personal Products SG-05 0.01 Bn -1.03 0.00 Mn 0.01 Bn
22 CABR Caring Brands, Inc. primary S-11 Household and Personal Products SG-05 0.01 Bn -1.08 — 0.01 Bn
23 BIOE Bio Essence Corp primary S-11 Household and Personal Products SG-05 0.01 Bn 6.04 0.00 Mn 0.01 Bn
24 AIXN AiXin Life International, Inc. primary S-11 Household and Personal Products SG-05 0.01 Bn -3.18 0.00 Mn 0.01 Bn
25 DQWS DSwiss Inc primary S-11 Household and Personal Products SG-05 0.01 Bn -27.32 0.00 Mn 0.01 Bn
26 JWEL Jowell Global Ltd. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.79 0.00 Mn 0.00 Bn
27 TCRG Cannaisseur Group Inc. primary S-11 Household and Personal Products SG-05 0.00 Bn -3.37 — 0.00 Bn
28 ATPC Agape ATP Corp primary S-11 Household and Personal Products SG-05 0.00 Bn -2.05 0.00 Mn 0.00 Bn
29 ACBM Acro Biomedical Co., Ltd. primary S-11 Household and Personal Products SG-05 0.00 Bn -20.67 — 0.00 Bn
30 JUNS Jupiter Neurosciences, Inc. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.17 0.00 Mn 0.00 Bn
31 HIGR Hi-Great Group Holding Co primary S-11 Household and Personal Products SG-05 0.00 Bn -13.55 0.00 Mn 0.00 Bn
32 SNYR Synergy CHC Corp. primary S-11 Household and Personal Products SG-05 0.00 Bn -0.08 0.00 Mn 0.00 Bn
33 JNJ Johnson & Johnson secondary H-01 Pharmaceuticals and Biotechnology HG-01 643.26 Bn 30.58 0.00 Mn 622.50 Bn
34 ABBV AbbVie Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 443.31 Bn 70.19 0.00 Mn 436.74 Bn
35 MRK Merck & Co., Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 364.74 Bn 115.10 0.00 Mn 357.60 Bn
36 PG PROCTER & GAMBLE Co secondary S-10 Household and Personal Products SG-05 332.67 Bn 20.61 0.00 Mn 322.72 Bn
37 AMGN Amgen Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 211.73 Bn 24.22 0.00 Mn 197.74 Bn
38 GILD Gilead Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 180.92 Bn -62.49 0.00 Mn 177.74 Bn
39 VRTX Vertex Pharmaceuticals Inc / Ma secondary H-02 Pharmaceuticals and Biotechnology HG-01 132.16 Bn 30.00 0.00 Mn 124.30 Bn
40 REGN Regeneron Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 82.89 Bn 19.15 0.00 Mn 74.90 Bn
41 COR Cencora, Inc. secondary H-19 Healthcare Payers and Distributors HG-05 62.63 Bn 23.73 0.00 Mn 59.81 Bn
42 ARGX Argenx Se secondary H-02 Pharmaceuticals and Biotechnology HG-01 61.41 Bn 35.80 0.00 Mn 56.23 Bn
43 MRNA Moderna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 53.99 Bn -17.13 0.00 Mn 48.85 Bn
44 SNY Sanofi secondary H-01 Pharmaceuticals and Biotechnology HG-01 52.33 Bn 11.23 0.00 Mn 44.95 Bn
45 TEVA Teva Pharmaceutical Industries Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 42.84 Bn 61.56 0.00 Mn 39.19 Bn
46 ADM Archer-Daniels-Midland Co secondary S-07 Agribusiness SG-03 41.79 Bn 23.49 0.00 Mn 32.22 Bn
47 IDXX Idexx Laboratories Inc /De secondary H-05 Pharmaceuticals and Biotechnology HG-01 40.69 Bn 35.70 0.00 Mn 40.49 Bn
48 ALNY Alnylam Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 34.48 Bn 44.51 0.00 Mn 31.18 Bn
49 BIIB Biogen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 31.15 Bn 37.32 0.00 Mn 29.86 Bn
50 ZTS Zoetis Inc. secondary H-05 Pharmaceuticals and Biotechnology HG-01 30.63 Bn 9.36 0.00 Mn 28.95 Bn
51 ROIV Roivant Sciences Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 30.05 Bn -20.25 0.00 Mn 30.05 Bn
52 INSM INSMED Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 27.99 Bn -31.97 0.00 Mn 26.83 Bn
53 INCY Incyte Corp secondary H-01 Pharmaceuticals and Biotechnology HG-01 25.23 Bn 15.65 0.00 Mn 20.69 Bn
54 BNTX BioNTech SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 23.72 Bn -13.92 0.00 Mn 10.06 Bn
55 CHD Church & Dwight Co Inc /De/ secondary S-10 Household and Personal Products SG-05 22.57 Bn 30.30 0.00 Mn 22.31 Bn
56 VTRS Viatris Inc secondary H-04 Pharmaceuticals and Biotechnology HG-01 19.13 Bn -46.58 0.00 Mn 18.24 Bn
57 ZBH Zimmer Biomet Holdings, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 18.20 Bn 21.48 0.00 Mn 17.79 Bn
58 MDGL Madrigal Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn -49.74 0.00 Mn 15.03 Bn
59 ASND Ascendis Pharma A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 15.87 Bn 18.30 0.00 Mn 14.92 Bn
60 NBIX Neurocrine Biosciences Inc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.65 Bn 22.19 0.00 Mn 15.26 Bn
61 JAZZ Jazz Pharmaceuticals plc secondary H-01 Pharmaceuticals and Biotechnology HG-01 15.22 Bn 16.17 0.00 Mn 13.60 Bn
62 BBIO BridgeBio Pharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 14.90 Bn -21.53 0.00 Mn 14.18 Bn
63 EXEL Exelixis, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 14.62 Bn 16.98 0.00 Mn 13.78 Bn
64 SMMT Summit Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 13.63 Bn — — 12.94 Bn
65 HALO Halozyme Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.58 Bn 30.43 0.00 Mn 12.35 Bn
66 BMRN Biomarin Pharmaceutical Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 12.45 Bn 170.57 0.00 Mn 11.57 Bn
67 ARWR Arrowhead Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 11.85 Bn -43.53 0.00 Mn 10.24 Bn
68 ELAN Elanco Animal Health Inc secondary H-05 Pharmaceuticals and Biotechnology HG-01 11.77 Bn -59.16 0.00 Mn 11.24 Bn
69 CLX Clorox Co /De/ secondary S-10 Household and Personal Products SG-05 10.92 Bn 18.17 0.00 Mn 10.78 Bn
70 AAVXF Abivax S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
71 AXSM Axsome Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 10.89 Bn -70.84 0.00 Mn 10.57 Bn
72 APGE Apogee Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
73 GMED Globus Medical Inc secondary H-06 Medical Devices and Diagnostics HG-02 10.11 Bn 18.88 0.00 Mn 9.51 Bn
74 PRAX Praxis Precision Medicines, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 10.05 Bn -26.35 — 9.29 Bn
75 RDY Dr Reddys Laboratories Ltd secondary H-04 Pharmaceuticals and Biotechnology HG-01 9.91 Bn 785.46 0.00 Mn 9.74 Bn
76 PTGX Protagonist Therapeutics, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.56 Bn 86.62 0.00 Mn 9.56 Bn
77 IONS Ionis Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 9.24 Bn -43.52 0.00 Mn 7.18 Bn
78 GPCR Structure Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 8.96 Bn -47.63 — 8.96 Bn
79 PCVX Vaxcyte, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.59 Bn -8.13 — 8.59 Bn
80 IBRX ImmunityBio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.54 0.00 Mn 8.12 Bn
81 CHWY Chewy, Inc. secondary S-04 Branded Foods SG-02 8.46 Bn 33.13 0.00 Mn 7.94 Bn
82 IMVT Immunovant, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.97 Bn -14.81 — 7.97 Bn
83 TGTX Tg Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.77 Bn 17.59 0.00 Mn 7.09 Bn
84 GIFLF Grifols SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.00 Mn 9.09 Bn
85 SYRE Spyre Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.38 Bn -41.27 — 7.38 Bn
86 SRRK Scholar Rock Holding Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 7.14 Bn -17.69 — 7.14 Bn
87 CELH Celsius Holdings, Inc. secondary S-03 Beverages SG-01 7.05 Bn 117.53 0.00 Mn 6.42 Bn
88 RYTM Rhythm Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.93 Bn -32.98 0.00 Mn 6.60 Bn
89 CGON CG Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.36 Bn -28.39 0.00 Mn 6.36 Bn
90 BLCO Bausch & Lomb Corp secondary H-06 Medical Devices and Diagnostics HG-02 6.33 Bn -38.86 0.00 Mn 5.96 Bn
91 BLRX BioLineRx Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.31 Bn -704.68 0.00 Mn 6.31 Bn
92 MIRM Mirum Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.25 Bn -7.27 0.00 Mn 5.82 Bn
93 KNSA Kiniksa Pharmaceuticals International, plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 6.09 Bn 75.51 0.00 Mn 5.56 Bn
94 XENE Xenon Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn -16.20 — 5.87 Bn
95 COGT Cogent Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.84 Bn -15.79 — 5.84 Bn
96 DBVT DBV Technologies S.A. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.83 Bn -33.11 0.00 Mn 5.65 Bn
97 LGND Ligand Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.78 Bn 29.31 0.00 Mn 4.42 Bn
98 ORKA Oruka Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.74 Bn — — 4.01 Bn
99 PTCT Ptc Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn 14.70 0.00 Mn 3.39 Bn
100 CELC Celcuity Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.98 Bn -22.73 — 4.98 Bn
101 ERAS Erasca, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.89 Bn -17.03 — 4.89 Bn
102 DNLI Denali Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.06 Bn -7.94 0.00 Mn 4.06 Bn
103 DNTH Dianthus Therapeutics, Inc. /DE/ secondary H-02 Pharmaceuticals and Biotechnology HG-01 4.05 Bn — — 3.64 Bn
104 TLPPF Telix Pharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 0.00 Mn 3.59 Bn
105 VKTX Viking Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.83 Bn -7.15 — 3.83 Bn
106 RLAY Relay Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.80 Bn -13.27 0.00 Mn 3.80 Bn
107 IOVA Iovance Biotherapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 3.79 Bn -18.13 0.00 Mn 3.49 Bn
108 AMLX Amylyx Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.60 Bn -29.59 — 3.60 Bn
109 RCUS Arcus Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -7.79 0.00 Mn 2.88 Bn
110 TNGX Tango Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -34.90 0.00 Mn 2.56 Bn
111 IPAR Interparfums Inc secondary S-12 Household and Personal Products SG-05 3.57 Bn 17.39 0.00 Mn 3.36 Bn
112 IDYA IDEAYA Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -16.07 0.00 Mn 2.71 Bn
113 ABCL AbCellera Biologics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn -20.49 0.00 Mn 3.37 Bn
114 DYN Dyne Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.18 Bn -6.15 — 3.18 Bn
115 ARQT Arcutis Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.11 Bn 109.08 0.00 Mn 2.87 Bn
116 CLDX Celldex Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 3.02 Bn -9.83 0.02 Mn 3.02 Bn
117 MBX MBX Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -28.68 — 2.99 Bn
118 IMNM Immunome Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.96 Bn -10.96 0.00 Mn 2.44 Bn
119 IRON Disc Medicine, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -14.67 — 2.95 Bn
120 NRIX Nurix Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.93 Bn -8.57 0.00 Mn 2.48 Bn
121 ZLAB Zai Lab Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.80 Bn -14.90 0.00 Mn 2.10 Bn
122 WDFC Wd 40 Co secondary S-10 Household and Personal Products SG-05 2.69 Bn 30.13 0.00 Mn 2.63 Bn
123 SLS SELLAS Life Sciences Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.64 Bn -81.36 — 2.64 Bn
124 TAK Takeda Pharmaceutical Co Ltd secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.61 Bn 4.54 0.00 Mn -3.19 Bn
125 NEOG Neogen Corp secondary H-08 Medical Devices and Diagnostics HG-02 2.59 Bn -365.72 0.00 Mn 2.41 Bn
126 OCUL Ocular Therapeutix, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -8.52 0.00 Mn 2.58 Bn
127 AXGN Axogen, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 2.51 Bn -169.96 0.00 Mn 2.40 Bn
128 BEIGF BeOne Medicines Ltd. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.48 Bn 3.74 0.00 Mn -2.62 Bn
129 VERA Vera Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -6.10 — 2.44 Bn
130 SUPN Supernus Pharmaceuticals, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.44 Bn -28.71 0.00 Mn 2.07 Bn
131 NKTR Nektar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn -20.29 0.00 Mn 1.73 Bn
132 HRMY Harmony Biosciences Holdings, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 13.50 0.00 Mn 1.60 Bn
133 VRDN Viridian Therapeutics, Inc.\DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -5.99 0.00 Mn 2.40 Bn
134 SRPT Sarepta Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -16.97 0.00 Mn 1.53 Bn
135 XTLB Xtl Biopharmaceuticals Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -2,975.41 — 2.29 Bn
136 BCRX Biocryst Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -5.95 0.00 Mn 1.94 Bn
137 NUVB Nuvation Bio Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.28 Bn -21.11 0.00 Mn 2.28 Bn
138 URGN UroGen Pharma Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -36.49 0.00 Mn 2.16 Bn
139 BHVN Biohaven Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.27 Bn -3.87 — 2.00 Bn
140 PHVS Pharvaris N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.24 — 1.86 Bn
141 ADMA Adma Biologics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.91 0.00 Mn 2.01 Bn
142 GMAB Genmab A/S secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.17 0.00 Mn 0.63 Bn
143 KOD Kodiak Sciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -8.78 — 2.12 Bn
144 AUPH Aurinia Pharmaceuticals Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 2.11 Bn 6.70 0.00 Mn 1.66 Bn
145 AGIO Agios Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -5.01 0.00 Mn 2.06 Bn
146 RAPP Rapport Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.06 Bn -15.00 0.00 Mn 2.06 Bn
147 CMPS COMPASS Pathways plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.04 Bn -5.16 — 2.04 Bn
148 ZBIO Zenas BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 2.03 Bn -4.89 0.00 Mn 2.03 Bn
149 SPB Spectrum Brands Holdings, Inc. secondary S-04 Branded Foods SG-02 1.99 Bn 23.49 0.00 Mn 1.73 Bn
150 ZYME Zymeworks Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -13.21 0.00 Mn 1.71 Bn
151 STOK Stoke Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.98 Bn -9.53 0.00 Mn 1.69 Bn
152 BFLY Butterfly Network, Inc. secondary H-08 Medical Devices and Diagnostics HG-02 1.96 Bn -26.25 0.00 Mn 1.84 Bn
153 XNCR Xencor Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.89 Bn -11.60 0.00 Mn 1.52 Bn
154 VIR Vir Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.82 Bn -7.23 0.00 Mn 1.82 Bn
155 SNDX Syndax Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.77 Bn -9.74 0.00 Mn 1.22 Bn
156 INBX Inhibrx Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn -13.23 0.00 Mn 1.76 Bn
157 IMCR Immunocore Holdings plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.75 Bn -96.63 0.00 Mn 0.87 Bn
158 GLPGF Lakefront Biotherapeutics NV secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 0.00 Mn 1.73 Bn
159 RXRX Recursion Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -3.31 0.00 Mn 1.17 Bn
160 SEPN Septerna, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -122.77 0.00 Mn 1.71 Bn
161 GHRS GH Research PLC secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -26.90 — 1.31 Bn
162 DMRA Damora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.19 — 1.09 Bn
163 NVAX Novavax Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -6.57 0.00 Mn 0.91 Bn
164 SCNI Scinai Immunotherapeutics Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.63 Bn -194.01 0.00 Mn 1.62 Bn
165 ANAB Anaptysbio, Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -67.19 0.00 Mn 1.32 Bn
166 BCAX Bicara Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -8.63 — 1.60 Bn
167 ATAI AtaiBeckley Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn -10.33 0.00 Mn 1.59 Bn
168 FBRX Forte Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
169 AAPG Ascentage Pharma Group International secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -9.11 0.00 Mn 1.26 Bn
170 PAHC Phibro Animal Health Corp secondary H-05 Pharmaceuticals and Biotechnology HG-01 1.49 Bn 14.92 0.00 Mn 1.41 Bn
171 RARE Ultragenyx Pharmaceutical Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn -3.17 0.00 Mn 1.17 Bn
172 ANRO Alto Neuroscience, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -17.48 — 1.46 Bn
173 MAZE Maze Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 0.00 Mn 1.45 Bn
174 GLUE Monte Rosa Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.37 0.00 Mn 0.81 Bn
175 SDGR Schrodinger, Inc. secondary T-27 Vertical Software TG-05 1.44 Bn -26.48 0.00 Mn 1.03 Bn
176 TYRA Tyra Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn -9.65 — 1.43 Bn
177 AVBP ArriVent BioPharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn -8.67 — 1.42 Bn
178 REPL Replimune Group, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -4.73 — 1.40 Bn
179 OMER Omeros Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn 82.16 0.00 Mn 1.40 Bn
180 SVRA Savara Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -9.82 — 1.37 Bn
181 ABSI Absci Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn -11.30 0.00 Mn 1.17 Bn
182 NMAX Newsmax Inc. secondary C-05 Advertising and Media CG-02 1.37 Bn -17.21 0.00 Mn 1.32 Bn
183 ORIC Oric Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.64 — 1.36 Bn
184 CGEM Cullinan Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -6.49 — 1.33 Bn
185 VOR Vor Biopharma Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -1.37 — 1.27 Bn
186 ALMS Alumis Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.18 0.00 Mn 0.75 Bn
187 CRVS Corvus Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.23 Bn -25.77 — 1.02 Bn
188 MNKD Mannkind Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -28.00 0.00 Mn 1.11 Bn
189 JANX Janux Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -11.87 0.00 Mn 1.22 Bn
190 JBIO Jade Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.56 — 1.16 Bn
191 CLYM Climb Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.84 — 1.14 Bn
192 IMTX Immatics N.V. secondary H-03 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -4.64 0.00 Mn 0.66 Bn
193 ABUS Arbutus Biopharma Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.02 Bn 6.67 0.00 Mn 0.92 Bn
194 MLTX MoonLake Immunotherapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn -3.82 — 0.48 Bn
195 OKYO OKYO Pharma Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn -118.02 — 0.99 Bn
196 WVE Wave Life Sciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -4.81 0.00 Mn 0.61 Bn
197 MNPR Monopar Therapeutics secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -70.03 — 0.92 Bn
198 ARDX Ardelyx, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -17.06 0.00 Mn 0.67 Bn
199 GERN Geron Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -13.99 0.00 Mn 0.64 Bn
200 ODD Oddity Tech Ltd secondary S-12 Household and Personal Products SG-05 0.93 Bn 12.71 0.00 Mn 0.63 Bn
201 TBPH Theravance Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.84 0.00 Mn 0.49 Bn
202 RIGL Rigel Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 2.72 0.00 Mn 0.78 Bn
203 ANNX Annexon, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn -4.26 — 0.87 Bn
204 STTK Shattuck Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.82 Bn -15.12 0.00 Mn 0.82 Bn
205 VSTM Verastem, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -6.91 0.00 Mn 0.66 Bn
206 AVTX Avalo Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.80 Bn -7.93 — 0.80 Bn
207 ACRS Aclaris Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.89 0.00 Mn 0.79 Bn
208 CTMX CytomX Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -10.21 0.00 Mn 0.44 Bn
209 PHAR Pharming Group N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -122.18 0.00 Mn 0.60 Bn
210 ZURA Zura Bio Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn -6.21 — 0.72 Bn
211 ZVRA Zevra Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 12.24 0.00 Mn 0.49 Bn
212 AURA Aura Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn -6.22 — 0.61 Bn
213 IRWD Ironwood Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.67 Bn 3.03 0.00 Mn 0.59 Bn
214 SLN Silence Therapeutics plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -16.42 0.00 Mn 0.57 Bn
215 CRMD CorMedix Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 5.07 0.00 Mn 0.38 Bn
216 HELE Helen Of Troy Ltd secondary D-06 Household Durables DG-02 0.63 Bn -1.54 0.00 Mn 0.61 Bn
217 EVOH EvoAir Holdings Inc. secondary I-14 Construction Products IG-03 0.63 Bn -56.89 0.00 Mn 0.62 Bn
218 ASMB Assembly Biosciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn 502.49 0.00 Mn 0.30 Bn
219 ALT Altimmune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.62 Bn -8.43 — 0.62 Bn
220 CBIO Crescent Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -3.75 0.00 Mn 0.44 Bn
221 OCS Oculis Holding AG secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -340,055.90 — 0.60 Bn
222 BWMX Betterware De Mexico, S.A.P.I. De C.V secondary S-12 Household and Personal Products SG-05 0.58 Bn 10.21 0.00 Mn 0.55 Bn
223 TECX Tectonic Therapeutic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn -6.72 — 0.58 Bn
224 VALN Valneva SE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.79 0.00 Mn 0.43 Bn
225 SGMT Sagimet Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -11.82 — 0.57 Bn
226 ARVN Arvinas, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 61.21 0.00 Mn 0.00 Bn
227 CTNM Contineum Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.40 — 0.57 Bn
228 FLGT Fulgent Genetics, Inc. secondary H-17 Healthcare Providers HG-04 0.56 Bn -6.62 0.00 Mn 0.30 Bn
229 BBOT BridgeBio Oncology Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -2.72 — 0.32 Bn
230 OVID Ovid Therapeutics Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.53 Bn -15.37 0.00 Mn 0.41 Bn
231 OABI OmniAb, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.67 0.00 Mn 0.46 Bn
232 IMUX Immunic, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -4.48 — 0.52 Bn
233 PRLD Prelude Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.41 0.00 Mn 0.22 Bn
234 PRTA Prothena Corp Public Ltd Co secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -11.04 0.00 Mn 0.20 Bn
235 CNTN Canton Strategic Holdings, Inc. secondary T-58 Fintech TG-09 0.48 Bn -5.85 0.00 Mn 0.48 Bn
236 KMDA Kamada Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.22 0.00 Mn 0.40 Bn
237 NEUP Neuphoria Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.72 — 0.45 Bn
238 ANL Adlai Nortye Ltd. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.27 0.00 Mn 0.23 Bn
239 RLMD Relmada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.55 — 0.46 Bn
240 PBYI Puma Biotechnology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 15.39 0.00 Mn 0.37 Bn
241 CYPH Cypherpunk Technologies Inc. secondary T-58 Fintech TG-09 0.45 Bn 7.62 — 0.45 Bn
242 DRUG Bright Minds Biosciences Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.52 — 0.45 Bn
243 CCCC C4 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -4.44 0.00 Mn 0.20 Bn
244 AVIR Atea Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.09 — 0.42 Bn
245 RZLT Rezolute, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -5.18 — 0.42 Bn
246 ARCT Arcturus Therapeutics Holdings Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -4.40 0.00 Mn 0.23 Bn
247 CMPX Compass Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -5.07 — 0.41 Bn
248 BIOA BioAge Labs, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn -4.36 0.00 Mn 0.41 Bn
249 LRMR Larimar Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.28 — 0.24 Bn
250 EVMN Evommune, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.14 0.00 Mn 0.19 Bn
251 ENTA Enanta Pharmaceuticals Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -6.09 0.00 Mn 0.19 Bn
252 HMDCF HUTCHMED (China) Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
253 EYPT EyePoint, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.21 0.00 Mn 0.19 Bn
254 OFIX Orthofix Medical Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.36 Bn -8.34 0.00 Mn 0.26 Bn
255 CATX Perspective Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -3.02 — 0.36 Bn
256 OCGN Ocugen, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -4.39 0.00 Mn 0.26 Bn
257 WHWK Whitehawk Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn -4.36 — 0.35 Bn
258 PRE Prenetics Global Ltd secondary H-08 Medical Devices and Diagnostics HG-02 0.34 Bn -7.19 0.00 Mn 0.28 Bn
259 FHTX Foghorn Therapeutics Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -5.03 0.00 Mn 0.26 Bn
260 UPB Upstream Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -2.03 0.00 Mn 0.32 Bn
261 ELDN Eledon Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.86 — 0.32 Bn
262 EPRX Eupraxia Pharmaceuticals Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.37 — 0.32 Bn
263 CLLS Cellectis S.A. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -7.50 0.00 Mn 0.14 Bn
264 STRO Sutro Biopharma, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -2.69 0.00 Mn 0.14 Bn
265 TRDA Entrada Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -1.82 0.00 Mn 0.30 Bn
266 AGEN Agenus Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.08 0.00 Mn 0.28 Bn
267 EQ Equillium, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.70 — 0.28 Bn
268 BCYC Bicycle Therapeutics Plc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.46 0.00 Mn 0.28 Bn
269 TLSI TriSalus Life Sciences, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -4.74 0.00 Mn 0.23 Bn
270 ACIU AC Immune SA secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.13 0.00 Mn 0.28 Bn
271 ANIK Anika Therapeutics, Inc. secondary H-06 Medical Devices and Diagnostics HG-02 0.28 Bn -130.67 0.00 Mn 0.24 Bn
272 SABS SAB Biotherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.04 — 0.28 Bn
273 GALT Galectin Therapeutics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -9.52 — 0.27 Bn
274 MGNX Macrogenics Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -16.20 0.00 Mn 0.15 Bn
275 AKBA Akebia Therapeutics, Inc. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -8.70 0.00 Mn 0.10 Bn
276 ANTX AN2 Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.05 — 0.26 Bn
277 FIXX Q32 Bio Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 63.96 — 0.15 Bn
278 AVXL Anavex Life Sciences Corp. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -18.19 — 0.14 Bn
279 IVVD Invivyd, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.01 0.00 Mn 0.09 Bn
280 ALXO Alx Oncology Holdings Inc secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.12 — 0.25 Bn
281 CAMP Camp4 Therapeutics Corp secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -5.05 0.00 Mn 0.25 Bn
282 ALEC Alector, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.87 0.00 Mn 0.08 Bn
283 CYDY CytoDyn Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -7.46 — 0.25 Bn
284 NUS Nu Skin Enterprises, Inc. secondary S-12 Household and Personal Products SG-05 0.23 Bn -1.06 0.00 Mn 0.04 Bn
285 TARA Protara Therapeutics, Inc. secondary H-03 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.34 — 0.23 Bn
286 CELG-RI Bristol Myers Squibb Co secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.03 0.00 Mn -10.83 Bn
287 SRZN Surrozen, Inc./DE secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.80 0.00 Mn 0.23 Bn
288 CGEN Compugen Ltd secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.54 0.00 Mn 0.14 Bn
289 KRRO Korro Bio, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.77 0.00 Mn 0.11 Bn
290 KROS Keros Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.49 0.00 Mn -0.03 Bn
291 NMRA Neumora Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.36 — 0.22 Bn
292 PYXS Pyxis Oncology, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.34 0.00 Mn 0.19 Bn
293 GLSI Greenwich LifeSciences, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.88 — 0.22 Bn
294 PEPG PepGen Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -3.02 — 0.22 Bn
295 PLX Protalix BioTherapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 10.07 0.00 Mn 0.17 Bn
296 TNXP Tonix Pharmaceuticals Holding Corp. secondary H-01 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.33 0.00 Mn 0.21 Bn
297 PRQR ProQR Therapeutics N.V. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -4.28 0.00 Mn 0.07 Bn
298 PTNM Pitanium Ltd secondary S-12 Household and Personal Products SG-05 0.21 Bn -63.51 0.00 Mn -2.70 Bn
299 ABOS Acumen Pharmaceuticals, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.98 — 0.21 Bn
300 FTH Faeth Therapeutics, Inc. secondary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.05 — 0.21 Bn